Home LiteratureArticle Details
PMID: 20490962 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Radiation-induced cell death mechanisms.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine ·Vol. 31 ·No. 4 ·2010-08-00 ·Pages 363-72

Eriksson D, Stigbrand T

Abstract

The main goal when treating malignancies with radiation therapy is to deprive tumor cells of their reproductive potential. One approach to achieve this is by inducing tumor cell apoptosis. Accumulating evidences suggest that induction of apoptosis alone is insufficient to account for the therapeutic effect of radiotherapy. It has become obvious in the last few years that inhibition of the proliferative capacity of malignant cells following irradiation, especially with solid tumors, can occur via alternative cell death modalities or permanent cell cycle arrests, i.e., senescence. In this review, apoptosis and mitotic catastrophe, the two major cell deaths induced by radiation, are described and dissected in terms of activating mechanisms. Furthermore, treatment-induced senescence and its relevance for the outcome of radiotherapy of cancer will be discussed. The importance of p53 for the induction and execution of these different types of cell deaths is highlighted. The efficiency of radiotherapy and radioimmunotherapy has much to gain by understanding the cell death mechanisms that are induced in tumor cells following irradiation. Strategies to use specific inhibitors that will manipulate key molecules in these pathways in combination with radiation might potentiate therapy and enhance tumor cell kill.

MeSH Terms
Animals Apoptosis/radiation effects Cellular Senescence/radiation effects Humans Mitosis/radiation effects Neoplasms/radiotherapy Tumor Suppressor Protein p53/physiology
Chemicals
Tumor Suppressor Protein p53
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Eriksson David
Department of Immunology, University of Umeå, 90185 Umeå, Sweden. david.eriksson@climi.umu.se
Stigbrand Torgny
References (140)
140 references, click to expand
  1. Fas is involved in the p53-dependent apoptotic response to ionizing radiation in mouse testis.
    Biol Reprod. 2002 May;66(5):1456-61 PMID: 11967210
  2. Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy.
    Oncogene. 2004 May 27;23(25):4362-70 PMID: 15048075
  3. Molecular mechanisms of caspase regulation during apoptosis.
    Nat Rev Mol Cell Biol. 2004 Nov;5(11):897-907 PMID: 15520809
  4. Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers.
    Cancer Res. 2005 Apr 1;65(7):2795-803 PMID: 15805280
  5. Overview of cell death signaling pathways.
    Cancer Biol Ther. 2005 Feb;4(2):139-63 PMID: 15725726
  6. Structure meets function--centrosomes, genome maintenance and the DNA damage response.
    Exp Cell Res. 2006 Aug 15;312(14):2633-40 PMID: 16854412
  7. Roles of cyclins A and E in induction of centrosome amplification in p53-compromised cells.
    Oncogene. 2008 Sep 11;27(40):5288-302 PMID: 18490919
  8. Radiation response of cell organelles.
    Micron. 2000 Apr;31(2):165-81 PMID: 10588063
  9. Cell cycle disturbances and mitotic catastrophes in HeLa Hep2 cells following 2.5 to 10 Gy of ionizing radiation.
    Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5501s-5508s PMID: 17875782
  10. Origins of G1 arrest in senescent human fibroblasts.
    Bioessays. 1995 Jun;17(6):537-43 PMID: 7575495
  11. DNA damage is able to induce senescence in tumor cells in vitro and in vivo.
    Cancer Res. 2002 Mar 15;62(6):1876-83 PMID: 11912168
  12. The role of p53 in determining sensitivity to radiotherapy.
    Nat Rev Cancer. 2003 Feb;3(2):117-29 PMID: 12563311
  13. Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death.
    Cancer Cell. 2005 Jul;8(1):7-12 PMID: 16023594
  14. Desmoid tumors in adults: the role of radiotherapy in their management.
    Am J Surg. 1988 Jun;155(6):754-60 PMID: 3132051
  15. G2 checkpoint abrogators as anticancer drugs.
    Mol Cancer Ther. 2004 Apr;3(4):513-9 PMID: 15078995
  16. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha.
    Cancer Res. 1998 Apr 15;58(8):1593-8 PMID: 9563466
  17. Iodine-131 induces mitotic catastrophes and activates apoptotic pathways in HeLa Hep2 cells.
    Cancer Biother Radiopharm. 2008 Oct;23(5):541-9 PMID: 18986216
  18. Limiting the proliferation of polyploid cells.
    Cell. 2007 Nov 2;131(3):437-40 PMID: 17981108
  19. Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis.
    Nat Genet. 2000 Sep;26(1):122-7 PMID: 10973264
  20. DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells.
    J Pharmacol Exp Ther. 2002 Oct;303(1):124-31 PMID: 12235242
  21. Combined low dose radio- and radioimmunotherapy of experimental HeLa Hep 2 tumours.
    Eur J Nucl Med Mol Imaging. 2003 Jun;30(6):895-906 PMID: 12721768
  22. The senescence-associated secretory phenotype: the dark side of tumor suppression.
    Annu Rev Pathol. 2010;5:99-118 PMID: 20078217
  23. Cytostatic activity of paclitaxel in coronary artery smooth muscle cells is mediated through transient mitotic arrest followed by permanent post-mitotic arrest: comparison with cancer cells.
    Cell Cycle. 2006 Jul;5(14):1574-9 PMID: 16861892
  24. P53 and radiation responses.
    Oncogene. 2003 Sep 1;22(37):5774-83 PMID: 12947385
  25. Awakening guardian angels: drugging the p53 pathway.
    Nat Rev Cancer. 2009 Dec;9(12):862-73 PMID: 19935675
  26. Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment.
    Cell Death Differ. 1998 Jul;5(7):584-91 PMID: 10200513
  27. Molecular signaling and genetic pathways of senescence: Its role in tumorigenesis and aging.
    J Cell Physiol. 2007 Mar;210(3):567-74 PMID: 17133363
  28. The expanding role of mitochondria in apoptosis.
    Genes Dev. 2001 Nov 15;15(22):2922-33 PMID: 11711427
  29. Cytokine expression and signaling in drug-induced cellular senescence.
    Oncogene. 2010 Jan 14;29(2):273-84 PMID: 19802007
  30. Death and anti-death: tumour resistance to apoptosis.
    Nat Rev Cancer. 2002 Apr;2(4):277-88 PMID: 12001989
  31. Chromosome segregation and cancer: cutting through the mystery.
    Nat Rev Cancer. 2001 Nov;1(2):109-17 PMID: 11905802
  32. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics.
    Clin Cancer Res. 2008 Aug 15;14(16):5000-5 PMID: 18698017
  33. Expression and regulation of Bcl-2, Bcl-xl, and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia.
    Blood. 1997 Apr 15;89(8):2986-93 PMID: 9108419
  34. Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation.
    Biochem Pharmacol. 2008 Oct 15;76(8):947-57 PMID: 18657518
  35. Radiation response of mouse lymphoid and myeloid cell lines. Part II. Apoptotic death is shown by all lines examined.
    Int J Radiat Biol. 1994 Feb;65(2):217-27 PMID: 7907119
  36. A comprehensive study of p53 transcriptional activity in thymus and spleen of gamma irradiated mouse: high sensitivity of genes involved in the two main apoptotic pathways.
    Int J Radiat Biol. 2006 Nov;82(11):761-70 PMID: 17148260
  37. Prediction of radiosensitivity of oral cancers by serial cytological assay of nuclear changes.
    Radiother Oncol. 1998 Oct;49(1):61-5 PMID: 9886699
  38. Cell death by mitotic catastrophe: a molecular definition.
    Oncogene. 2004 Apr 12;23(16):2825-37 PMID: 15077146
  39. Aurora kinases as anticancer drug targets.
    Clin Cancer Res. 2008 Mar 15;14(6):1639-48 PMID: 18347165
  40. Caspase-9 and APAF-1 form an active holoenzyme.
    Genes Dev. 1999 Dec 15;13(24):3179-84 PMID: 10617566
  41. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53.
    Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9648-53 PMID: 9275177
  42. Radiation-induced senescence-like growth arrest requires TP53 function but not telomere shortening.
    Radiat Res. 2001 Jan;155(1 Pt 2):248-253 PMID: 11121242
  43. Spindle checkpoint function and cellular sensitivity to antimitotic drugs.
    Mol Cancer Ther. 2006 Dec;5(12):2963-9 PMID: 17172401
  44. Apoptosis regulation in tetraploid cancer cells.
    EMBO J. 2006 Jun 7;25(11):2584-95 PMID: 16675948
  45. p16/MTS1/INK4A suppresses prostate cancer by both pRb dependent and independent pathways.
    Oncogene. 2000 Mar 2;19(10):1297-306 PMID: 10713671
  46. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.
    Cell. 1997 Nov 14;91(4):479-89 PMID: 9390557
  47. p53 in growth control and neoplasia.
    Biochim Biophys Acta. 1996 Jun 7;1287(2-3):77-102 PMID: 8672531
  48. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors.
    Cell. 1998 Aug 21;94(4):481-90 PMID: 9727491
  49. On the TRAIL from p53 to apoptosis?
    Nat Genet. 1997 Oct;17(2):130-1 PMID: 9326922
  50. How does radiation kill cells?
    Curr Opin Chem Biol. 1999 Feb;3(1):77-83 PMID: 10021401
  51. Hallmarks of senescence in carcinogenesis and cancer therapy.
    Oncogene. 2004 Apr 12;23(16):2919-33 PMID: 15077154
  52. Tumor cell senescence in cancer treatment.
    Cancer Res. 2003 Jun 1;63(11):2705-15 PMID: 12782571
  53. Living with p53, dying of p53.
    Cell. 2007 Aug 24;130(4):597-600 PMID: 17719538
  54. p16 INK4a can initiate an autonomous senescence program.
    Oncogene. 2000 Mar 23;19(13):1613-22 PMID: 10763818
  55. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo.
    Oncogene. 2001 Aug 2;20(34):4601-12 PMID: 11498783
  56. Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy.
    Mol Cancer. 2009 Feb 13;8:8 PMID: 19216791
  57. Oncogenes and tumour suppressors take on centrosomes.
    Nat Rev Cancer. 2007 Dec;7(12):911-24 PMID: 18004399
  58. New concepts in radiation-induced apoptosis: 'premitotic apoptosis' and 'postmitotic apoptosis'.
    J Cell Mol Med. 2001 Jul-Sep;5(3):240-53 PMID: 12067483
  59. p53 is required for radiation-induced apoptosis in mouse thymocytes.
    Nature. 1993 Apr 29;362(6423):847-9 PMID: 8479522
  60. Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome.
    J Mol Med (Berl). 2007 Nov;85(11):1175-86 PMID: 17589818
  61. Thymocyte apoptosis induced by p53-dependent and independent pathways.
    Nature. 1993 Apr 29;362(6423):849-52 PMID: 8479523
  62. Radiation-induced apoptosis: relevance to radiotherapy.
    Int J Radiat Oncol Biol Phys. 1995 Nov 1;33(4):781-96 PMID: 7591884
  63. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells.
    Drug Resist Updat. 2001 Oct;4(5):303-13 PMID: 11991684
  64. BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo.
    Blood. 2005 Dec 15;106(13):4131-8 PMID: 16118324
  65. Involvement of centrosome amplification in radiation-induced mitotic catastrophe.
    Cell Cycle. 2007 Feb 1;6(3):364-70 PMID: 17297293
  66. Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes.
    Genes Dev. 2008 Aug 15;22(16):2189-203 PMID: 18662975
  67. Two faces of p53: aging and tumor suppression.
    Nucleic Acids Res. 2007;35(22):7475-84 PMID: 17942417
  68. Cancer: a matter of life cycle?
    Cell Biol Int. 2007 Dec;31(12):1507-10 PMID: 17936649
  69. Effects of the multidrug transporter P-glycoprotein on cellular responses to ionizing radiation.
    Cancer Res. 2000 May 15;60(10):2576-8 PMID: 10825123
  70. Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin.
    J Biol Chem. 2002 May 10;277(19):17154-60 PMID: 11877436
  71. DNA damage induces Chk1-dependent centrosome amplification.
    EMBO Rep. 2007 Jun;8(6):603-9 PMID: 17468739
  72. p53: guardian of the genome and policeman of the oncogenes.
    Cell Cycle. 2007 May 2;6(9):1006-10 PMID: 17457049
  73. hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes.
    Cell. 2007 Aug 24;130(4):638-50 PMID: 17719542
  74. p53 mutation heterogeneity in cancer.
    Biochem Biophys Res Commun. 2005 Jun 10;331(3):834-42 PMID: 15865939
  75. Restoration of wild-type p53 function in human tumors: strategies for efficient cancer therapy.
    Adv Cancer Res. 2007;97:321-38 PMID: 17419952
  76. The p53 pathway: positive and negative feedback loops.
    Oncogene. 2005 Apr 18;24(17):2899-908 PMID: 15838523
  77. p53-Dependent accelerated senescence induced by ionizing radiation in breast tumour cells.
    Int J Radiat Biol. 2005 Jun;81(6):445-58 PMID: 16308915
  78. Caspase-2 function in response to DNA damage.
    Biochem Biophys Res Commun. 2005 Jun 10;331(3):859-67 PMID: 15865942
  79. Cell cycle kinases as therapeutic targets for cancer.
    Nat Rev Drug Discov. 2009 Jul;8(7):547-66 PMID: 19568282
  80. Caspase substrates.
    Cell Death Differ. 2007 Jan;14(1):66-72 PMID: 17082814
  81. Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1.
    J Biol Chem. 2000 Oct 6;275(40):31199-203 PMID: 10940292
  82. Radiation-induced acute immediate nuclear abnormalities in oral cancer cells: serial cytologic evaluation.
    Acta Cytol. 1998 Sep-Oct;42(5):1084-90 PMID: 9755662
  83. p53 induced growth arrest versus apoptosis and its modulation by survival cytokines.
    Cell Cycle. 2007 Jan 15;6(2):166-70 PMID: 17264673
  84. Tetraploidy, aneuploidy and cancer.
    Curr Opin Genet Dev. 2007 Apr;17(2):157-62 PMID: 17324569
  85. Cancer. p53, guardian of the genome.
    Nature. 1992 Jul 2;358(6381):15-6 PMID: 1614522
  86. Preferential killing of tetraploid tumor cells by targeting the mitotic kinesin Eg5.
    Cell Cycle. 2009 Apr 1;8(7):1030-5 PMID: 19270519
  87. Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint.
    Dev Cell. 2004 Nov;7(5):637-51 PMID: 15525526
  88. p53 modulation of the DNA damage response.
    J Cell Biochem. 2007 Mar 1;100(4):883-96 PMID: 17031865
  89. Senescence in tumours: evidence from mice and humans.
    Nat Rev Cancer. 2010 Jan;10(1):51-7 PMID: 20029423
  90. Cellular senescence and cancer treatment.
    Biochim Biophys Acta. 2007 Jan;1775(1):5-20 PMID: 17027159
  91. Centrosome hyperamplification and chromosomal damage after exposure to radiation.
    Oncology. 2004;67(5-6):460-70 PMID: 15714003
  92. P53, cyclin-dependent kinase and abnormal amplification of centrosomes.
    Biochim Biophys Acta. 2008 Sep;1786(1):15-23 PMID: 18472015
  93. Telomere dysfunction and tumour suppression: the senescence connection.
    Nat Rev Cancer. 2008 Jun;8(6):450-8 PMID: 18500246
  94. Down-regulation of bcl-2 by p53 in breast cancer cells.
    Cancer Res. 1994 Apr 15;54(8):2095-7 PMID: 8174112
  95. Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivation.
    Cell. 2007 Aug 24;130(4):624-37 PMID: 17719541
  96. Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis.
    Oncogene. 1994 Dec;9(12):3743-51 PMID: 7970735
  97. [Mitotic catastrophe: a special case of apoptosis].
    J Soc Biol. 2004;198(2):97-103 PMID: 15368957
  98. Induction of centrosome amplification in p53 siRNA-treated human fibroblast cells by radiation exposure.
    Cancer Sci. 2006 Apr;97(4):252-8 PMID: 16630116
  99. Two CD95 (APO-1/Fas) signaling pathways.
    EMBO J. 1998 Mar 16;17(6):1675-87 PMID: 9501089
  100. Segregation of genomes in polyploid tumour cells following mitotic catastrophe.
    Cell Biol Int. 2005 Dec;29(12):1005-11 PMID: 16314119
  101. Identification of a p53-dependent negative response element in the bcl-2 gene.
    Cancer Res. 1994 Jun 15;54(12):3131-5 PMID: 8205530
  102. Radiation-induced apoptosis.
    Cell Tissue Res. 2000 Jul;301(1):133-42 PMID: 10928286
  103. The microtubule stabilizing agent discodermolide is a potent inducer of accelerated cell senescence.
    Cell Cycle. 2005 Mar;4(3):501-7 PMID: 15711127
  104. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents.
    Cancer Res. 1999 Aug 1;59(15):3761-7 PMID: 10446993
  105. Oncology. Recruiting the cell's own guardian for cancer therapy.
    Science. 2007 Mar 2;315(5816):1211-3 PMID: 17332387
  106. The identification of senescence-specific genes during the induction of senescence in prostate cancer cells.
    Neoplasia. 2005 Sep;7(9):816-23 PMID: 16229804
  107. Lack of p53 function promotes radiation-induced mitotic catastrophe in mouse embryonic fibroblast cells.
    Cancer Cell Int. 2006 Apr 26;6:11 PMID: 16640786
  108. P53 promoter selection: choosing between life and death.
    Cell Cycle. 2008 Jan 15;7(2):154-7 PMID: 18212532
  109. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion.
    Nat Cell Biol. 2009 Aug;11(8):973-9 PMID: 19597488
  110. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa.
    Science. 2003 Nov 7;302(5647):1036-8 PMID: 14500851
  111. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene.
    Nat Genet. 1997 Oct;17(2):141-3 PMID: 9326928
  112. Transcriptional regulation by p53: one protein, many possibilities.
    Cell Death Differ. 2006 Jun;13(6):951-61 PMID: 16575405
  113. Aurora kinase inhibitors.
    Crit Rev Oncol Hematol. 2010 Feb;73(2):99-110 PMID: 19369091
  114. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent.
    Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):389-94 PMID: 11752408
  115. Reasons to reconsider the significance of apoptosis for cancer therapy.
    Int J Radiat Biol. 2003 Dec;79(12):927-41 PMID: 14713571
  116. In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute.
    Cell Death Differ. 2008 Jun;15(6):1019-29 PMID: 18259198
  117. p53 mutations in human cancers.
    Science. 1991 Jul 5;253(5015):49-53 PMID: 1905840
  118. Do prostatic biopsies 12 months or more after external irradiation for adenocarcinoma, Stage III, predict long-term survival?
    Int J Radiat Oncol Biol Phys. 1983 Mar;9(3):299-303 PMID: 6404866
  119. Induction of accelerated senescence by gamma radiation in human solid tumor-derived cell lines expressing wild-type TP53.
    Radiat Res. 2005 Jan;163(1):53-62 PMID: 15606307
  120. Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction.
    J Biol Chem. 2002 Sep 20;277(38):35509-15 PMID: 12101184
  121. Assessing TP53 status in human tumours to evaluate clinical outcome.
    Nat Rev Cancer. 2001 Dec;1(3):233-40 PMID: 11902578
  122. An accelerated senescence response to radiation in wild-type p53 glioblastoma multiforme cells.
    J Neurosurg. 2006 Jul;105(1):111-8 PMID: 16871885
  123. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy.
    Cell. 2002 May 3;109(3):335-46 PMID: 12015983
  124. A dominant role for p53-dependent cellular senescence in radiosensitization of human prostate cancer cells.
    Cell Cycle. 2007 Mar 1;6(5):595-605 PMID: 17351335
  125. Up-regulation of Fas (CD95) in human p53wild-type cancer cells treated with ionizing radiation.
    Int J Cancer. 1997 Nov 27;73(5):757-62 PMID: 9398058
  126. Role of p53 in regulating constitutive and X-radiation-inducible CD95 expression and function in carcinoma cells.
    Cancer Res. 2003 Nov 1;63(21):7176-84 PMID: 14612511
  127. DNA damage-induced apoptosis.
    Oncogene. 2004 Apr 12;23(16):2797-808 PMID: 15077143
  128. Cell cycle progression after cleavage failure: mammalian somatic cells do not possess a "tetraploidy checkpoint".
    J Cell Biol. 2004 Jun 7;165(5):609-15 PMID: 15184397
  129. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas.
    Nature. 2007 Feb 8;445(7128):656-60 PMID: 17251933
  130. From polyploidy to aneuploidy, genome instability and cancer.
    Nat Rev Mol Cell Biol. 2004 Jan;5(1):45-54 PMID: 14708009
  131. Cell death modalities: classification and pathophysiological implications.
    Cell Death Differ. 2007 Jul;14(7):1237-43 PMID: 17431418
  132. Apoptosis: controlled demolition at the cellular level.
    Nat Rev Mol Cell Biol. 2008 Mar;9(3):231-41 PMID: 18073771
  133. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways.
    Cancer Cell. 2003 Oct;4(4):321-8 PMID: 14585359
  134. The serial cultivation of human diploid cell strains.
    Exp Cell Res. 1961 Dec;25:585-621 PMID: 13905658
  135. Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence.
    Cancer Res. 2002 Sep 1;62(17):5076-82 PMID: 12208764
  136. Structural and functional basis for therapeutic modulation of p53 signaling.
    Clin Cancer Res. 2008 Oct 15;14(20):6376-86 PMID: 18927276
  137. p53-independent apoptosis and p53-dependent block of DNA rereplication following mitotic spindle inhibition in human cells.
    Exp Cell Res. 1999 Aug 1;250(2):339-50 PMID: 10413588
  138. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.
    J Biol Chem. 2002 Feb 1;277(5):3247-57 PMID: 11714700
  139. Apoptotic signalling in HeLa Hep2 cells following 5 Gy of cobalt-60 gamma radiation.
    Anticancer Res. 2009 Nov;29(11):4361-6 PMID: 20032379
  140. Restoration of p53 to limit tumor growth.
    Curr Opin Oncol. 2008 Jan;20(1):90-6 PMID: 18043262
Article Info
Journal
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Abbr.
Tumour Biol
ISSN
1423-0380
Published
2010-08-00
Epub
2010-00-20
Pages
363-72
Language
English
Region
Netherlands
NLM ID
8409922
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com